Feel powerful and safe.
Gain metabolic health.

OneTwenty lets you see your blood sugar levels 120 minutes ahead.

Start looking forward and stop harmful trial-and-error corrections.

Become an early member now and secure your seat.

Our closed beta starts later in 2022.

Be in charge. Tap into the power of AI to gain glycemic control to feel better. Everyday.

Automatic Tracking

We detect events, foods and stress directly from your glucose feed.

AI Powered

Our deep learning models reduce tedious tasks like manual measurements.

Continuous Metabolic Care

Get guidance instead of raw data. Get personalized education instead of generic guidelines. All in real time.

Pre-alpha user interface

We interpret your health data in real time and deliver insights instead of raw values.
So you can focus on living.

Pre-alpha wearable interface

For better decisions, not more.

We leverage the power of data from wearables and continuous glucose measurements (CGM) to give you the right options at the right time – not more values to watch.

Learn how

Stabilize your blood sugar.

Reduce your metabolic stress by taking the „right turns“ and leave unexpected spikes or lows, exhaustion and feeling bloated behind.

Learn how
OneTwenty - Guidance
OneTwenty.Ai - Body Favorites

Learn your body's favorites.

Learn how your body reacts to foods – even before you eat them – and finally find the diet and activities that work best for you.

Learn how

Impact that you feel everday.
Lower variability, easier weight loss, increased prospects of remission.

0 x
More T2D Remissions¹
0 x
Less Spikes & Lows²
0 x
Higher Weight Loss³

¹Results after 180-day in-silico simulations with T2D health data, compared to best practice remission rates reported in Lean et al., The Lancet Volume 391 (Issue 10120)

²Results for 90-day in-silico simulations, reported as mean including data from T1Diabetics, T2Diabetics and PreDiabetics

³In-silico results compared to average body weight loss of 2.9% with standard treatment for T2Diabetics as reported by Jones et al., 2020; 45(03)

Sign up now to
get early beta access.

Become an early member now and secure your seat.

Our closed beta starts later in 2022.

Ready to take your diabetes care to the next level?

Get In Touch

Company

Service & Resources

  • Whitepaper (soon)
  • FAQ (Soon)
  • Publications (soon)

© Copyright 2024 OneTwenty AG, All rights reserved.

¹ PMID: 19254969; https://doi.org/10.1155/2020/1834534; https://doi.org/10.1007/s00125-021-05396-5; PMID: 26649106; PMID: 34790639
² https://doi.org/10.1002/edm2.379; https://doi.org/10.2337/dci21-0043; 12 week measurements compared to study baselines
³ Reported time <50mg/dL across all subjects over 12 weeks: average of 0.78% and median of 0.21% time spent in hypoglycemia
⁴ ML prediction up to a 120 minute horizon and accuracy per point measurement at 76.8% ±4.2% 

bioX is an investigational solution limited by Swiss law to investigational use. Not available for sale. To be clear, bioX is not yet commercially available because it has not yet been cleared by the MDR or FDA or any other regulatory body. We will have to obtain regulatory clearances before we can offer it for commercial sale.

OneTwenty and bioX are registered trademarks of OneTwenty AG. Other trademarks are the property of their respective owners. No use of any OneTwenty AG trademark, trade name, or trade dress in this site may be made without the prior written authorisation of OneTwenty AG, except to identify the product or services of the company. The product images are for illustrative purposes only.

For better decisions, not more.

Learn how the shift to insight based decision making, can drastically improve your quality of life.

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua.

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat, vel illum dolore eu feugiat nulla facilisis at vero eros et accumsan et iusto odio dignissim qui blandit praesent luptatum zzril delenit augue duis dolore te feugait nulla facilisi. Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.

Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat, vel illum dolore eu feugiat nulla facilisis at vero eros et accumsan et iusto odio dignissim qui blandit praesent luptatum zzril delenit augue duis dolore te feugait nulla facilisi.

Nam liber tempor cum soluta nobis eleifend option congue nihil imperdiet doming id quod mazim placerat facer